Advertisement
Rapid Communication| Volume 56, ISSUE 2, P164-167, March 2003

Pseudo-tumoral proliferative nodule in a giant congenital nævus

  • A. de Vooght
    Correspondence
    Correspondence to: Axel de Vooght
    Affiliations
    Department of Plastic and Reconstructive Surgery, St-Luc University Hospital (Brussels)—Catholic University of Louvain-10 av. Hippocrate, B-1200 Brussels, Belgium
    Search for articles by this author
  • R. Vanwijck
    Affiliations
    Department of Plastic and Reconstructive Surgery, St-Luc University Hospital (Brussels)—Catholic University of Louvain-10 av. Hippocrate, B-1200 Brussels, Belgium
    Search for articles by this author
  • S. Gosseye
    Affiliations
    Department of Pathologic Anatomy, St-Luc University Hospital (Brussels)—Catholic University of Louvain-10 av. Hippocrate, B-1200 Brussels, Belgium
    Search for articles by this author
  • B. Bayet
    Affiliations
    Department of Plastic and Reconstructive Surgery, St-Luc University Hospital (Brussels)—Catholic University of Louvain-10 av. Hippocrate, B-1200 Brussels, Belgium
    Search for articles by this author

      Abstract

      Objective: To discuss the characteristics of proliferative nodules in giant congenital nævi. Methods: We report the case of a newborn referred for staged curettage of a giant congenital nævus. A nodule was discovered on his left flank. It was excised for analysis during the first treatment session during the second week of life. Results: The nodule was soft and looked like a lipoma. On optical microscopy however, there was a high cellular density and a high number of mitoses. Although the genetic analysis for melanoma antigens was reassuring, a firm nodule recurred a few days later. A second excision was performed at the fourth week. Surprisingly, on optical microscopy, the cellular density was much lower and there were no more atypias or mitoses; many neurotization foci were present. The natural history changed to spontaneous regression of the cellular activity. The diagnosis of proliferative nodule was made. Conclusion: Proliferative nodules in giant congenital nævi have specific clinical and histological characteristics. These should however be put into perspective. As demonstrated in this case, there can be an initial high mitotic activity within the nodule but this should not lead to the misdiagnosis of malignant melanoma. The spontaneous regression of cellular activity will allow the correct diagnosis to be made.

      Keywords

      Giant congenital nævi (GCN) may be accompanied by proliferative nodules. These are lesions that have specific histological characteristics: high cellularity, absence of high-grade nuclear atypia, low mitotic rate, smooth transition between the cells in the nodule and the adjacent nævus cells.
      • Elder D
      • Elenitsas R
      Benign pigmented lesions and malignant melanoma.
      We report the case of a proliferative nodule of an atypical type.

      1. Case report

      Our patient was a full term male with no significant family or personal history. On physical examination, he presented with a GCN of the bathing trunk type (Fig. 1) . He was referred for surgical treatment. Because of the size of the nævus, we decided to perform a staged early curettage following the Johnson principle.
      • Johnson H.A
      Permanent removal of pigmentation from giant hairy nevi by dermabrasion in early life.
      Figure thumbnail gr1
      Figure 1Patient with a giant congenital nævus (bathing trunk type).
      The first curettage session was performed on the tenth day. At that time, a two-centimetre soft nodule was discovered by palpation on the left flank (Fig. 2) . This nodule was excised for analysis. At cross-section, we found yellowish tissue, which looked like a simple lipoma. Optical microscopy was however surprising. The nodule was located in the deep dermis and in the subcutaneous tissue (Fig. 3) . The limits of the nodule were well defined. Nevertheless, at higher magnification, there was no capsule. There was a blending between the cells of the nodule and the cells of the adjacent nævus (Fig. 4) . The cellularity was high (Fig. 5) . Cells showed round nuclei, pyknosis, some anisokaryosis and contour irregularities. The cells of the nodule were similar to those of the dermal nævus (Fig. 6) but with higher pleomorphism and a high number of mitoses.
      Figure thumbnail gr2
      Figure 2Two-centimetre soft nodule (arrow) discovered on the left flank of the baby.
      Figure thumbnail gr3
      Figure 3Nodule situation—10th day of life—H&E×2.
      Figure thumbnail gr4
      Figure 4Higher magnification of the transition zone between the nodule and the dermis (arrow—)—H&E×32.
      Figure thumbnail gr5
      Figure 5Higher magnification of the nodule: high cellularity; high number of mitoses (arrows)—H&E×130.
      Figure thumbnail gr6
      Figure 6Dermal portion of the nævus: dense nævocellular nævus—H&E×130.
      To go further in the diagnosis, additional investigations were performed. Although some of the melanoma associated antigens were present (Melan-A; Tyrosinase; gp100-hmb45), the tumour was negative for MAGE genes 1, 3 and 10.
      At the second curettage session performed at the fourth week of life, there was evidence of nodule recurrence. Its characteristics had changed. The nodule was indurated. On cross-section, we found a pearly dense tissue. On optical microscopy, the nodule was made up of connective tissue with a moderately dense population of nævus cells. There were many neurotization foci (Fig. 7) . At higher magnification, no more atypias or mitosis were observed (Fig. 8) . There was spontaneous regression of cellular activity within the nodule.
      Figure thumbnail gr7
      Figure 7Nodule at the 4th week of life: presence of neurotization foci (arrows)—H&E×32.
      Figure thumbnail gr8
      Figure 8Higher magnification of the nodule at the 4th week of life: low cellularity; absence of mitoses—H&E×130.

      2. Discussion

      The risk of developing malignant melanoma in GCN has been evaluated at between 1.9 and 6%.
      • Quaba A.A
      • Wallace A.F
      The incidence of malignant melanoma (0 to 15 years of age) arising in large congenital nevocellular nevi.
      • Ruiz-Maldonado R
      • Tamayo L
      • Laterza A.M
      • Duran C
      Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations.
      • Swerdlow A.J
      • English J.S.C
      • Qiao Z
      The risk of melanoma in patients with congenital nevi: a cohort study.
      • Marghoob A.A
      • Schoenbach S.P
      • Kopf A.W
      • et al.
      Large congenital melanocytic nevi and the risk for the development of malignant melanoma.
      • Egan C.L
      • Oliveira S.A
      • Elenitsas R
      • Hanson J
      • Halpern A.C
      Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients.
      • Bittencourt F.V
      • Marghoob A.A
      • Kopf A.W
      • Koenig K.L
      • Bart R.S
      Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis.
      • DeDavid M
      • Orlow S.J
      • Provost N
      • et al.
      A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature.
      At time of diagnosis, the patient is usually between 1 and 5 years of age (Table I) . The discovery of a nodule in a newborn with a GCN is thus of great concern. Biopsy should be obtained to get a precise histological diagnosis.
      Table IMelanoma and GNC
      Studies characteristicsQuaba 1986Ruiz-Maldonado 1992Swerdlow 1995Marghoob 1996Egan 1998Bittencourt 2000
      no. of patients3980339246160
      patients with melanoma232323
      mean age at entry into the study (years)N/A1.7N/A8.28.46.4
      mean age at diagnosis (years)3.45.7N/A1.33.11.3
      sex ratio (F/M)23/1652/28N/A54/3822/2489/71
      mean follow-up (years)8.64.7N/A5.47.35.5
      risk (%)2/39 (5.1)3/80 (3.8)2/33 (6)3/92 (3.3)2/46 (4.3)3/160 (1.9)
      cumulative risk8.5%
      Risk between 0 to 15 years.
      N/AN/A4.5%
      Risk between 0 to 5 years.
      5.7%
      Risk between 0 to 5 years.
      2.3%
      Risk between 0 to 5 years.
      N/A: Non available.
      a Risk between 0 to 15 years.
      b Risk between 0 to 5 years.
      Previously described ‘proliferative nodules’ had specific well defined characteristics: papule or nodule present around birth; surface smooth or seldom ulcerated; slow or no growth; cells in nodule larger than in nævus; cells in nodule blend with surrounding benign nævus cells; low mitotic index; little or no inflammation and no necrosis.
      • Borbujo J
      • Jara M
      • Cortes L
      • Sanchez de Leon L
      A newborn with nodular ulcerated lesion on a giant congenital nevus.
      • Lowes M.A
      • Norris D
      • Whitfeld M
      Benign melanocytic proliferative nodule within a congenital nævus.
      • Kerl H
      • Soyer H.P
      Proliferative nodules in congenital nevi.
      Our case report demonstrates how difficult the exact identification of such proliferative lesions in a GCN can be. Histological patterns can be very confusing.
      Indeed, at the second week of life, the lesion excised on the left flank of our young patient presented with all the signs of a malignant pigmented neoplasm: pigmented cells grouped in a nodular formation showing high cellularity, nuclear atypia, a slight degree of pleomorphism and a very high mitotic index. There was a high suspicion of malignant melanoma. However, no advancing edge was observed. The blending between the cells of the nodule and the normal adjacent nævus cells suggested a differentiation process rather than a true neoplasm. Therefore, the excised lesion was to be considered as a ‘proliferation’ nodule but still nothing could be predicted in terms of benignity or malignancy. The fact that melanoma associated antigens were present (Melan-A; Tyrosinase; gp100-hmb45) had no significance since the nodule was situated in the deep dermis; pigmented cells of the overlying nævocellular nævus could simply have contaminated the sample. But the fact that the expression of MAGE genes 1, 3 and 10 was negative could not eliminate the diagnosis of melanoma (Table II) .
      • Brasseur F
      • Rimoldi D
      • Lienard D
      • et al.
      Expression of MAGE genes in primary and metastatic cutaneous melanoma.
      Table IIGenetic analysis
      Genetic analysisValues
      Mage genes 1, 3, 10
      Melan-A+++
      Tyrosinase++
      gp100 (hmb45)±
      Values range from − to +++.
      The natural history of the nodule allowed us to arrive at a firm diagnosis. In spite of recurrence and alarming appearance, the histological pattern of the recurrent nodule had completely changed. There was a clear regression of cellular activity. This was demonstrated by the absence of mitoses and by the many neurotization foci seen on optic microscopy.
      As demonstrated by this case, the previously described characteristics of proliferative nodules can be put into perspective. An initial high mitotic activity within the nodule should not be misdiagnosed as malignant melanoma. The cellular activity might spontaneously regress with time.
      However, since no such lesions have to our knowledge been published in the literature and since the origin of ‘proliferative nodules’ is still unknown, patients with similar lesions require a long term follow-up to detect later malignant transformation.

      3. Conclusion

      The melanoma transformation rate of GCN usually described in the literature is high.
      • Hendrickson M.R
      • Ross J.C
      Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature.
      • Briggs J.C
      Melanoma precursor lesions and borderline melanomas.
      • Reed R.J
      Minimal deviation malignant melanoma arising in a congenital nevus.
      • Muhlbauer J.E
      • Margolis R.J
      • Mihm Jr, M.C
      • Reed R.J
      Minimal deviation melanoma: a histologic variant of cutaneous malignant melanoma in its vertical growth phase.
      However, recent data obtained in large series of patients show a surprisingly much lower rate.
      • Marghoob A.A
      • Dusza S
      • Oliveria S
      • Halpern A
      Large congenital melanocytic nevi: an internet based, self-referred, prospective registry.
      This could be partially explained by misdiagnosis of melanoma-like lesions such as the one described in our report. As we have seen, proliferative nodules can be of an atypical type showing an initial high mitotic index with later spontaneous regression. Therefore, parents should not be unnecessarily alarmed.

      References

        • Elder D
        • Elenitsas R
        Benign pigmented lesions and malignant melanoma.
        in: Elder D Elenitsas R Jaworsky C Johnson Jr, B Lever's Histopathology of the Skin. 8th ed. Lippincott-Raven, Philadelphia1997: 647-648
        • Johnson H.A
        Permanent removal of pigmentation from giant hairy nevi by dermabrasion in early life.
        Br J Plast Surg. 1977; 30: 321-323
        • Quaba A.A
        • Wallace A.F
        The incidence of malignant melanoma (0 to 15 years of age) arising in large congenital nevocellular nevi.
        Plast Reconstr Surg. 1986; 78: 174-179
        • Ruiz-Maldonado R
        • Tamayo L
        • Laterza A.M
        • Duran C
        Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations.
        J Pediatr. 1992; 120: 906-911
        • Swerdlow A.J
        • English J.S.C
        • Qiao Z
        The risk of melanoma in patients with congenital nevi: a cohort study.
        J Am Acad Dermatol. 1995; 32: 595-599
        • Marghoob A.A
        • Schoenbach S.P
        • Kopf A.W
        • et al.
        Large congenital melanocytic nevi and the risk for the development of malignant melanoma.
        Arch Dermatol. 1996; 132: 170-175
        • Egan C.L
        • Oliveira S.A
        • Elenitsas R
        • Hanson J
        • Halpern A.C
        Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients.
        J Am Acad Dermatol. 1998; 39: 923-932
        • Bittencourt F.V
        • Marghoob A.A
        • Kopf A.W
        • Koenig K.L
        • Bart R.S
        Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis.
        Pediatrics. 2000; 106: 737-741
        • DeDavid M
        • Orlow S.J
        • Provost N
        • et al.
        A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature.
        J Am Acad Dermatol. 1997; 36: 409-416
        • Borbujo J
        • Jara M
        • Cortes L
        • Sanchez de Leon L
        A newborn with nodular ulcerated lesion on a giant congenital nevus.
        Pediatric Dermatol. 2000; 17: 299-301
        • Lowes M.A
        • Norris D
        • Whitfeld M
        Benign melanocytic proliferative nodule within a congenital nævus.
        Australas J Dermatol. 2000; 41: 109-111
        • Kerl H
        • Soyer H.P
        Proliferative nodules in congenital nevi.
        Melanoma Res. 2001; 11: S56
        • Brasseur F
        • Rimoldi D
        • Lienard D
        • et al.
        Expression of MAGE genes in primary and metastatic cutaneous melanoma.
        Int J Cancer. Nov 1995; 63: 375-380
        • Hendrickson M.R
        • Ross J.C
        Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature.
        Am J Surg Pathol. 1981; 5: 109-135
        • Briggs J.C
        Melanoma precursor lesions and borderline melanomas.
        Histopathology. 1985; 9: 1251-1262
        • Reed R.J
        Minimal deviation malignant melanoma arising in a congenital nevus.
        Am J Surg Pathol. 1978; 2: 215-220
        • Muhlbauer J.E
        • Margolis R.J
        • Mihm Jr, M.C
        • Reed R.J
        Minimal deviation melanoma: a histologic variant of cutaneous malignant melanoma in its vertical growth phase.
        J Invest Dermatol. 1983; 80: 63s-65s
        • Marghoob A.A
        • Dusza S
        • Oliveria S
        • Halpern A
        Large congenital melanocytic nevi: an internet based, self-referred, prospective registry.
        Pigment Cell Res. 2002; 15: 51-52

      Biography

      The Authors
      Axel de Vooght MD
      Romain Vanwijck MD
      Bénédicte Bayet MD,
      Department of Plastic and Reconstructive Surgery.
      Serge Gosseye MD,
      Department of Pathologic Anatomy,
      St-Luc University Hospital, Brussels.